Nuwellis Inc. (NUWE)
NASDAQ: NUWE
· Real-Time Price · USD
5.59
-0.05 (-0.89%)
At close: Aug 15, 2025, 3:59 PM
5.40
-3.40%
After-hours: Aug 15, 2025, 07:56 PM EDT
-0.89% (1D)
| Bid | 5.4 |
| Market Cap | 636.29K |
| Revenue (ttm) | 8.79M |
| Net Income (ttm) | -9.85M |
| EPS (ttm) | 630.42 |
| PE Ratio (ttm) | 0.01 |
| Forward PE | -0.13 |
| Analyst | Buy |
| Ask | 6.2 |
| Volume | 105,030 |
| Avg. Volume (20D) | 1,028,013 |
| Open | 5.50 |
| Previous Close | 5.64 |
| Day's Range | 5.25 - 5.89 |
| 52-Week Range | 4.82 - 175.98 |
| Beta | -0.01 |
About NUWE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NUWE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NUWE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Nuwellis has released their quartely earnings
on Aug 14, 2025:
4 weeks ago
-1.19%
NUWE stock has given up its prior loss. Nuwellis s...
Unlock content with
Pro Subscription
1 month ago
-1.19%
Nuwellis shares are trading lower after the company announced it has terminated its REVERSE-HF clinical trial to prioritize resources and redirect investment.
